Gilberto Castañeda-Hernández

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Venues

PloS one

Nutrients

Pharmaceutical patent analyst

American journal of hematology

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional Sep 09 1984

Mexico

Professor :: Pharmacology

Publications

Nadia Saavedra-Fuentes, Enrique Carmona-Montesinos, Gilberto Castañeda-Hernández, Israel Campos, Juan Carlos Castillo-Salinas, Javier Alberto Castillo-Tapia, Karla Guadalupe Del Castillo-Loreto, Juan Carlos Falcón-Martínez, Raquel Fuentes-García, Miguel Ángel García de León Guerrero, Victor García-García, Erika Fabiola Gómez-García, Rafael González-Toledo, Angélica Jaime, Kely Rely, Claudia Lerma, Luis E Morales-Buenrostro, Mateo Quilantan-Rodriguez, Adrián Rodriguez-Matías, Felipe Octavio Rojas-Rodriguez, Rafael Valdez-Ortiz, Michael Wasung, Berenice Ceron-Trujillo, Edgar Ramirez-Ramirez
Appropriateness of Ketoanalogues of Amino Acids, Calcium Citrate, and Inulin Supplementation for CKD Management: A RAND/UCLA Consensus. Nutrients 16 (17) (2024)
Claudia I Perez, Jorge Luis-Islas, Axel Lopez, Xarenny Diaz, Omar Molina, Benjamin Arroyo, Mario G Moreno, Elvi Gil Lievana, Esmeralda Fonseca, Gilberto Castañeda-Hernández, Ranier Gutierrez
Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PloS one 19 (4) (2024)
Claudia I Perez, Jorge Luis-Islas, Axel Lopez, Xarenny Diaz, Omar Molina, Benjamin Arroyo, Mario G Moreno, Elvi Gil Lievana, Esmeralda Fonseca, Gilberto Castañeda-Hernández, Ranier Gutierrez
Tesofensine, a novel antiobesity drug, silences GABAergic hypothalamic neurons. PloS one 19 (4) (2024)
Jessica L Vargas-Neri, Bruce C Carleton, Colin J D Ross, Mara Medeiros, Gilberto Castañeda-Hernández, Patricia Clark
Pharmacogenomic study of anthracycline-induced cardiotoxicity in Mexican pediatric patients. Pharmacogenomics 23 (5) (2022)
Rodrigo González-Ramírez, Gilberto Castañeda-Hernández
The challenges of developing and commercializing biosimilars in Latin America. Pharmaceutical patent analyst 8 (6) (2020)
Lorena Medina-Aymerich, Rodrigo González-Ramírez, Pilar García-Roca, Herlinda Reyes, Ana María Hernández, Mara Medeiros, Gilberto Castañeda-Hernández
Limited sampling strategy to predict the area under the curve of tacrolimus in Mexican renal transplant pediatric patients receiving Prograf® or non-innovator formulations. Pediatric transplantation 23 (8) (2019)
Arianna Rodríguez-Cal Y Mayor, Gilberto Castañeda-Hernández, Liliana Favari, Angelina Martinez-Cruz, Gabriel Guízar-Sahagún, Leticia Cruz-Antonio
Pharmacokinetics and anti-inflammatory effect of naproxen in rats with acute and subacute spinal cord injury. Naunyn-Schmiedeberg's archives of pharmacology 393 (3) (2019)
Guillermo Drelichman, Gilberto Castañeda-Hernández, Muhlis Cem Ar, Marta Dragosky, Ricardo Garcia, Howard Lee, Sergey V Moiseev, Majid Naderi, Hanna Rosenbaum, Irena Žnidar, Andrés Felipe Zuluaga, Selena Freisens, Pramod K Mistry
The road to biosimilars in rare diseases - ongoing lessons from Gaucher disease. American journal of hematology 95 (3) (2019)
Gilberto Castañeda-Hernández, Hugo Sandoval, Javier Coindreau, Luis Felipe Rodriguez-Davison, Carlos Javier Pineda-Villaseñor
Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey. Pharmacoepidemiology and drug safety 28 (8) (2019)
Arianna Rodríguez-Cal Y Mayor, Leticia Cruz-Antonio, Gilberto Castañeda-Hernández, Liliana Favari-Perozzi, Gabriel Guízar-Sahagún
Time-dependent changes in paw carrageenan-induced inflammation above and below the level of low thoracic spinal cord injury in rats. Spinal cord 56 (10) (2018)

Gilberto Castañeda-Hernández.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gilberto Castañeda-Hernández